University of Alabama at Birmingham, 311 THT — Birmingham, Alabama

University of Alabama at Birmingham, 311 THT is a clinical research site located in Birmingham, Alabama, United States 35294.

Crixeo Health Trust Score: 46/100 (POOR). This profile has not yet been claimed by the site owner.

University of Alabama at Birmingham, 311 THT has participated in 1 clinical trials.

Therapeutic areas: Systemic Sclerosis, Pulmonary Arterial Hypertension, Pulmonary Hypertension.

Sponsors: Actelion.

Sponsor Feasibility Report

Trust Score: 46/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Alabama at Birmingham, 311 THT?

University of Alabama at Birmingham, 311 THT has a Crixeo Trust Score of 46/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Alabama at Birmingham, 311 THT conducted?

University of Alabama at Birmingham, 311 THT has 1 clinical trials on record. Their work covers Systemic Sclerosis, Pulmonary Arterial Hypertension, Pulmonary Hypertension.

Is University of Alabama at Birmingham, 311 THT accredited by Crixeo Health?

University of Alabama at Birmingham, 311 THT has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Alabama at Birmingham, 311 THT?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.